Exfoliative dermatitis - Dermatitis Esfoliatiboa
☆ Alemaniako Stiftung Warentest-en 2022ko emaitzetan, ModelDerm-ekin kontsumitzaileen gogobetetasuna apur bat txikiagoa izan zen ordaindutako telemedikuntzako kontsultekin baino.
Red (burning) Skin Syndrome ― Eritema eta ezkata gorputz osoan dira Dermatitis Esfoliatiboa (Exfoliative dermatitis)ren sintoma nagusiak.
References
Erythroderma azaleko gaixotasun arraroa baina larria da. Kausa zehatza askotan ezezaguna den arren, droga-erreakzio batek edo azpiko minbizi batek eragin dezake. Dermatitis esfoliatiboarekin lotutako minbizi arrunt bat larruazaleko T zelulen linfoma da, eta baliteke larruazaleko egoera hasi eta hilabeteetan edo urte batzuetan sintomarik ez izatea. Normalean, ospitaleratzea behar da hasierako ebaluazioa eta tratamendua egiteko. Drogak eragindako gaixotasuna duten pazienteek, oro har, epe luzerako aurreikuspen ona dute, nahiz eta kausa argirik gabeko kasuek kurtso errepikakorra eta birsortzailea izan ohi duten. Minbiziari lotutako kasuen pronostikoa, normalean, minbiziak aurrera egiten duenaren araberakoa da.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Normalean, gorputzaren % 90 baino gehiago estaltzen duten gorritasuna eta maluta zabala erakusten du. Baldintza hau azpian dauden hainbat osasun arazoren seinale ikusgaia da, hala nola psoriasia, ekzema edo botika batzuen erantzuna.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Eritrodermaren kausa ohikoena azpiko larruazaleko gaixotasun baten areagotzea da, hala nola psoriasia, kontaktu dermatitis, dermatitis seborreikoa, liken planus, pityriasis rubra pilaris edo droga-erreakzio bat, hala nola esteroide topikoen erabilera. Manefestazio primarioa gutxiago izaten da eta larruazaleko T-zelulen linfoma kasuetan ikusten da normalean. Larruazaleko T zelulen linfomatik bereiztea garrantzitsua denez, biopsia egiten da.